AKT1 and Alzheimer disease: Further, several experiments on animal models revealed a marked increase in the phosphorylated Akt levels such as mammalian target of rapamycin (mTOR) and decreased cell-cycle inhibitors (p27kip1) in AD temporal cortex compared with control groups (Griffin et al., 2005[20]).